NCT05827575 is a NA clinical trial of Transcutaneous Auricular Vagal Nerve Stimulation in Functional Dyspepsia, sponsored by Second Affiliated Hospital of Xi'an Jiaotong University.

Who is sponsoring NCT05827575?

NCT05827575 is sponsored by Second Affiliated Hospital of Xi'an Jiaotong University.

What condition does NCT05827575 study?

NCT05827575 studies Functional Dyspepsia, Sleep Disturbances.

Is NCT05827575 still recruiting?

NCT05827575 is currently status unknown. Last updated 25 April 2023.

Last reviewed 2023-04-25 · How we verify

NCT05827575

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transcutaneous Auricular Vagal Nerve Stimulation for Functional Dyspepsia With Sleep Disturbances: a Randomized Controlled Trial

Status unknown NA Last updated 25 April 2023

What this trial tests

NA trial testing Transcutaneous Auricular Vagal Nerve Stimulation in Functional Dyspepsia in 60 participants. Status unknown.

Timeline

30 March 2022

Primary endpoint
30 June 2023

30 June 2023

Quick facts

Lead sponsor	Second Affiliated Hospital of Xi'an Jiaotong University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	30 March 2022
Primary completion	30 June 2023
Estimated completion	30 June 2023
Sites	1 location across China

Drugs / interventions tested

Transcutaneous Auricular Vagal Nerve Stimulation

Conditions studied

Functional Dyspepsia — all drugs for Functional Dyspepsia →
Sleep Disturbances — all drugs for Sleep Disturbances →

Sponsor

Second Affiliated Hospital of Xi'an Jiaotong University

Who can join

Adults 18 to 65, any sex, with Functional Dyspepsia or Sleep Disturbances. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Functional dyspepsia(FD) is most common in functional gastrointestinal disorders whose rick factors include sleep disturbances. The medication treatment for functional dyspepsia with sleep disturbances has disadvantages such as addiction and withdrawal symptoms. Transcutaneous auricular vagal nerve stimulation(taVNS) is a new therapeutic method to improve dyspepsia and sleep. Study on taSNS for FD with sleep disturbances has not yet been explored.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Transcutaneous auricular vagal nerve stimulation improves functional dyspepsia with sleep disturbance via enhanced vagal activity: a randomized controlled trial.
Li J, Wang L, Zhang Y, Meng R, et al · · 2026 · cited 1× · PMID 40905853 · DOI 10.1097/js9.0000000000003296

Verify or expand the search:

Other trials of Transcutaneous Auricular Vagal Nerve Stimulation

Trials testing the same drug.

NCT06381089 — Effect Of Robotic Rehabilitation And Vagus Nerve Stimulation In Ischemia Stroke Patients · NA · not yet recruiting

Other recruiting trials for Functional Dyspepsia

Currently open trials in the same condition.

NCT07442734 — Auricular Stimulation for Functional Dyspepsia With Insomnia: Efficacy and Mechanisms · NA · recruiting
NCT07250308 — Correlation Study of Atrophic Gastritis and Dyspepsia Symptoms · recruiting
NCT07187492 — Efficacy of Bacillus Coagulans in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia · Phase 4 · recruiting
NCT07182890 — Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia · Phase 4 · recruiting
NCT07210294 — Press Needle on Body Acupuncture Points and Auricular Acupuncture Points on Functional Dyspepsia · NA · recruiting

Other Second Affiliated Hospital of Xi'an Jiaotong University trials

Trials by the same sponsor.

NCT07160361 — Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB · Phase 4 · not yet recruiting
NCT07346456 — Comparison of IOL Formulas in Eyes With PCE≥15µm · completed
NCT06998589 — Comparison of the Efficacy and Safety of Delicate Pulsed Light and Q-Switched 1064 nm Nd:YAG Laser in the Treatment of P · NA · completed
NCT07305675 — Effectiveness of a rhGM-CSF-containing Gel on Promoting Recovery After 1927-nm Fractional Thulium Fiber Laser Treatment · NA · completed
NCT06791005 — A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer. · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05827575 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital of Xi'an Jiaotong University
Last refreshed: 25 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05827575.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing